Blog
Sanofi partners with Ipsos to understand hemophilia patientsâ needs and challenges
Sanofi’s extensive exploration into the world of hemophilia patients, caregivers, and healthcare providers has yielded valuable insights. Collaborating with The ...
Roche’s Vabysmo Preserves RVO Patients’ Vision with 4-Month Treatment Intervals in Phase III Trials
Roche has unveiled promising long-term findings from the global phase III BALATON and COMINO trials, which investigated the extended treatment ...
Biogen hires Grogan as R&D head, aims to boost innovation and agility
Dr. Jane Grogan, who recently assumed her role as the head of research at Biogen, is eager to bring the ...
Novartis halts depression drug trial, putting $210M Cadent buyout at risk
Novartis has made the decision to discontinue a mid-phase program aimed at treating major depressive disorder (MDD) with the investigational ...
Bayer opens new $250M facility in Berkeley to launch its cell therapy products
In a significant move to address the challenges of scaling up the production of cell therapies, Bayer, through its subsidiary ...
HistoSonics receives FDA approval for its ultrasound device that destroys liver tumors without surgery
In a groundbreaking move, the FDA has granted clearance to histotripsy technology, marking a significant milestone for HistoSonics and its ...
Ventyx reports positive phase 2 data for bowel disease drug, but fails to impress investors amid competition
Investors have shown skepticism toward Ventyx Biosciences’ attempt to challenge Bristol Myers Squibb and Pfizer in the ulcerative colitis market. ...
Akero Therapeuticsâ shares plummet after phase 2b trial of NASH drug fails to improve cirrhosis
Akero Therapeutics, a leading contender in the nonalcoholic steatohepatitis (NASH) field, has encountered a setback as its FGF21 analog, efruxifermin ...
Sanofi invests $10M in Proteome Sciences to access its protein map for drug discovery
Sanofi has taken a significant step toward its goal of becoming the first pharmaceutical company to harness the power of ...
Immunicâs MS drug shows positive biomarker results in phase 2 trial, boosting investor confidence
Immunic Therapeutics’ strategic decision to refocus its efforts earlier this year appears to be yielding positive results, drawing favorable reactions ...
Fujifilm Irvine Scientific and Formulated Solutions announce over 50 layoffs each, according to filings
In the midst of a recent wave of workforce reductions within the biopharma sector, two contract manufacturers have implemented significant ...
EuroAPI lowers sales forecast due to CDMO challenges and inventory cuts by customers
The Contract Development and Manufacturing Organization (CDMO) sector, which experienced a surge in business during the COVID-19 pandemic, is grappling ...
Novavax partners with TV show star to promote COVID-19 vaccine choice and awareness
Novavax is gearing up for a robust marketing push to secure a share of the COVID-19 booster vaccine market this ...
Lexicon hires former BMS executive Tom Garner as new commercial chief to launch Inpefa for heart failure
Lexicon Pharmaceuticals has faced numerous challenges in its journey to gain regulatory approval for its groundbreaking heart drug, Inpefa. After ...
Merckâs Keytruda extends survival of early lung cancer patients in trial, awaits FDA approval
Merck & Co.’s Keytruda has achieved a groundbreaking milestone in the treatment landscape for early-stage non-small cell lung cancer (NSCLC), ...
Salix Pharmaceuticals and Bellamy Young launch a campaign to raise awareness and support for hepatic encephalopathy patients
Salix Pharmaceuticals, a gastrointestinal subsidiary of Bausch Health, is teaming up with award-winning actor Bellamy Young to shed light on ...
GSK and Zhifei team up to distribute Shingrix in China and explore potential collaboration for RSV vaccine
GlaxoSmithKline has entered into a strategic partnership with Chongqing Zhifei Biological Products to distribute its shingles vaccine, Shingrix, in China. ...
Ascensia launches âBreak Up with Your CGMâ campaign to promote its long-term CGM system over Abbott and Dexcomâs products
Ascensia Diabetes Care and Senseonics have launched a strategic campaign aimed at enticing individuals away from market leaders Abbott and ...
Ablation procedures reduce heart failure risk by 57% in patients with atrial fibrillation, J&J study shows
An extensive retrospective study involving over 18,400 patients with atrial fibrillation (afib) has revealed that individuals who underwent cardiac ablation ...
QHP acquires Applied StemCell to strengthen its cell and gene therapy services for pharma clients
QHP Capital is expanding its portfolio of contract service providers by acquiring Applied StemCell (ASC), a specialized company in cell ...
Best Buy enters the CGM market with Dexcom G7 sensor as its first product
Best Buy is gearing up for the holiday season with an unexpected addition to its offerings: continuous glucose monitors (CGMs). ...
Eikon announces layoffs as part of its restructuring plan to improve efficiency and profitability
Eikon Therapeutics, a biotechnology company that attracted top executives from Merck & Co. and secured substantial financing, has implemented staff ...
Alnylam gives up on Onpattroâs US expansion after FDA rejects its rare heart disease indication
Despite receiving an endorsement from an advisory committee, the FDA has reached a different conclusion regarding the benefit-risk profile of ...
Delfi Diagnostics introduces a simple blood test to detect lung cancer early and accurately
Delfi Diagnostics is introducing its inaugural liquid biopsy test, fulfilling the long-standing vision of offering a groundbreaking blood-based screening tool ...
Anaptys reports positive results for its rare skin disease drug and seeks a partner for commercialization
AnaptysBio has unveiled promising phase 3 data for its rare skin disease drug candidate, indicating a potential challenge to Boehringer ...
Astellas launches TV campaign for Veozah, a new drug to treat hot flashes and other menopause symptoms
Astellas is revving up its efforts to transform the menopause drug Veozah into a standout product, and they’ve just hit ...
Bristol Myers Squibb acquires Mirati Therapeutics in a $5.8 billion deal to expand its cancer treatment portfolio
Mirati Therapeutics, long speculated to be a potential acquisition target in the world of Big Pharma, has now sealed a ...
National Cancer Group Raises Alarm Over Persistent Chemo Shortage Despite FDA’s Vigilant Efforts
Despite recent efforts by the White House and the FDA to address the chemotherapy shortage in the United States, a ...
FDA Demands Further Safety Testing from Philips Amid Ongoing Concerns over CPAP Recall Handling
Over two years into Philips’ ongoing recall of millions of respiratory devices, the FDA has expressed dissatisfaction with the progress ...
Amgen Successfully Completes $27.8B Acquisition of Horizon After FTC Dispute Resolution
Amgen has successfully concluded its monumental $27.8 billion acquisition of Horizon Therapeutics, triumphing over a legal challenge posed by the ...
